Help to improve the quality of life through the development and production of original peptide drugs, cosmetics, and nutraceuticals. Provision of scientific information, educational, and consulting services in peptide bioregulation.
Manus Pharmaceuticals (Canada) Ltd. (Manus) is a privately owned Canadian company established in 1993, focused on the research and development of novel, peptide-based biopharmaceutical medications, and nutraceutical supplements to successfully manage various immune, hematopoietic, and neurological diseases.
We have been developing a portfolio of promising novel drugs and drug candidates using our proprietary internationally patented discovery platform for exploring synthetic peptides.
Our experienced personal consulting in the areas of R&D in peptide design and synthesis, structure-functional modification, and cosmetic and active dermatology peptides.
Manus has a solid intellectual property position, with more than 50 patents issued worldwide for the compounds and scientific platform. In addition, the company holds patents in the United States, Canada, Eurasian, and the European Union countries.